The plasma logarithm of the triglyceride/HDL-cholesterol ratio is a predictor of low risk gestational diabetes in early pregnancy

Clinica Chimica Acta

Volumn 418, Issue , 2013, Pages 1-4

  dos Santos Weiss, Izabella C R ^a   Réa, Rosângela R ^b   Fadel Picheth, Cyntia M T ^a   Rego, Fabiane G M ^a   Pedrosa, Fábio de O ^a   Gillery, Philippe ^c   Souza, Emanuel M ^a   Picheth, Geraldo ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b Clinical Hospital   (Brazil)

^c UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

AIP index; Gestational diabetes; Lipid profile; Pregnancy; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENIC INDEX OF THE PLASMA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LIPID COMPOSITION; MAJOR CLINICAL STUDY; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PATIENT IDENTIFICATION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ATHEROSCLEROSIS; CHOLESTEROL, HDL; DIABETES, GESTATIONAL; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; RISK FACTORS; ROC CURVE; TRIGLYCERIDES;

EID: 84872731002     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.12.004     Document Type: Article

References (35)

1. Di Cianni G., Miccoli R., Volpe L., et al. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med 2005, 22:21-25.
2. Chiang A.N., Yang M.L., Hung J.H., Chou P., Shyn S.K., Ng H.T. Alterations of serum lipid levels and their biological relevances during and after pregnancy. Life Sci 1995, 56:2367-2375.
3. Toescu V., Nuttall S.L., Martin U., et al. Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin Sci 2004, 106:93-98.
4. Martin U., Davies C., Hayavi S., Hartland A., Dunne F. Is normal pregnancy atherogenic?. Clin Sci 1999, 96:421-425.
5. Wiznitzer A., Mayer A., Novack V., et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol 2009, 201:482e1-482e8.
6. Carpenter M.W. Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care 2007, 30(Suppl. 2):S246-S250.
7. Kim C., Newton K.M., Knopp R.H. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002, 25:1862-1868.
8. Butte N.F. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 2000, 71:1256S-1261S.
9. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl. 1):S62-S69.
10. Min Y., Nam J.H., Ghebremeskel K., Kim A., Crawford M. A distinctive fatty acid profile in circulating lipids of Korean gestational diabetics: a pilot study. Diabetes Res Clin Pract 2006, 73(2):178-183.
11. McGrowder D., Grant K., Irving R., et al. Lipid profile and clinical characteristics of women with gestational diabetes mellitus and preeclampsia. JMB 2009, 28:72-81.
12. HDL). Clin Biochem 2001, 34:583-588.
13. Tan M.H., Johns D., Glazer N.B. Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin Chem 2004, 50:1184-1188.
14. American Diabetes Association. Standards in medical care in diabetes. Diabetes Care 2009, 32(Suppl. 1):S13-S61.
15. American Diabetes Association Standards in medical care in diabetes. Diabetes Care 2012, 35(Suppl. 1):S11-S63.
16. Friedwald W.T., Levy R.I., Fredrickison D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of preparative ultracentrifuge. Clin Chem 1972, 18:499-552.
17. Castelli W.P., Garrison R.J., Wilson P.W.F., Abbot R.D., Kalousdian S., Kannel W.N. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Heart Study. JAMA 1986, 256:2835-2838.
18. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35(Suppl. 1):S64-S71.
19. Hadaegh F., Hatami M., Tohidi M., Sarbakhsh P., Saadat N., Azizi F. Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women. Lipids Health Dis 2010, 9:85.
20. Ordovas J.M., Pocovi M., Grande F. Plasma lipids and cholesterol esterification rate during pregnancy. Obstet Gynecol 1984, 63:20.
21. Enquobahrie D.A., Williams M.A., Qiu C., Luthy D.A. Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus. Diabetes Res Clin Pract 2005, 70:134-142.
22. Lauenborg J., Mathiesen E., Hansen T., et al. The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab 2005, 90:4004-4010.
23. AbouGhalia A.H., Khater L.M., El-Wahed M.A.A., El-Bradrawy M.F. Lipoprotein (a) and lipid profile in neonates from mother with three different types of diabetes mellitus. Clin Biochem 2003, 37:563-569.
24. Qiu C., Rudra C., Austin M.A., Williams M.A. Association of gestational diabetes mellitus and low-density lipoprotein (LDL) particle size. Physiol Res 2007, 56:571-578.
25. 10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol 2010, 4:89-98.
26. Hannon T.S., Bacha F., Lee S.J., Janosky J., Arslanian S.A. Use of markers of dyslipidemia to identify overweight youth with insulin resistance. Pediatr Diabetes 2006, 7:260-266.
27. McLaughlin T., Abbasi F., Cheal K., Chu J., Lamendola C., Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003, 139:802-809.
28. Soska V., Fiala J., Nebeska K., Jarkovsky J., Hruba D. The atherogenic index of plasma is increased by hormonal contraception. Scand J Clin Lab Invest 2011, 71:94-100.
29. Li C., Ford E.S., Meng Y.X., Mokdad A.H., Reaven G.M. Does the association of trigylceride to high-density lipoprotein colesterol ratio with fasting serum insulin differ by race/ethnicity?. Cardiovasc Diabetol 2007, 7:4.
30. Lain K.Y., Catalano P.M. Metabolic changes in pregnancy. Clin Obstet Gynecol 2007, 50:938-949.
31. Van den Elzen H.J., Wladimiroff J.W., Cohen-Overbeek T.E., de Bruijn A.J., Grobbee D.E. Serum lipids in early pregnancy and risk of pre-eclampsia. Br J Obstet Gynaecol 1996, 103:117-122.
32. Ray J.G., Diamond P., Singh G., Bell C.M. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG 2006, 113:379-386.
33. Herrera E., Ortega-Senovilla H. Disturbances in lipid metabolism in diabetic pregnancy - are these the cause of the problem?. Clin Endocrinol Metab 2010, 24:515-525.
34. Kitajima M., Oka S., Yasuhi I., Fukuda M., Rii Y., Ishimaru T. Maternal serum triglyceride at 24-32weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol 2001, 97:776-780.
35. Knopp R.H., Magee M.S., Walden C.E., Bonet B., Benedetti T.J. Prediction of infant birth weight by GDM screening tests. Importance of plasma triglyceride. Diabetes Care 1992, 15:1605-1613.